医学
内科学
危险系数
华登氏巨球蛋白血症
单变量分析
巨球蛋白血症
队列
胃肠病学
比例危险模型
乳酸脱氢酶
置信区间
多元分析
多发性骨髓瘤
淋巴瘤
生物化学
酶
化学
作者
Saurabh Zanwar,Jennifer Le‐Rademacher,Éric Durot,Shirley D’Sa,Jithma P. Abeykoon,Patrizia Mondello,Shaji Kumar,Shayna Sarosiek,Jonas Paludo,Saurabh Chhabra,Joselle Cook,Ricardo Parrondo,Angela Dispenzieri,Wilson I. Gonsalves,Eli Muchtar,Sikandar Ailawadhi,Robert A. Kyle,S. Vincent Rajkumar,Alain Delmer,Rafaël Fonseca
摘要
Patients with Waldenström macroglobulinemia (WM) have disparate outcomes. Newer therapies have emerged since the development of International Prognostic Scoring System, and
科研通智能强力驱动
Strongly Powered by AbleSci AI